Encyclopedia.com entry (Gale) et al., 2026-11-19: A biographical dictionary entry on Paul Janssen that places the discovery of mebendazole at Janssen Pharmaceutica in 1968 under compound code R 17635, marketed for humans as Vermox. The same entry records the 24 October 1961 share-swap takeover of the Janssen family company by Johnson & Johnson and the July 1981 mebendazole countertrade agreement with China.
In 1968, researchers at Janssen Pharmaceutica discovered mebendazole (R 17635), and somewhat later flubendazole (R 17889). These benzimidazole derivatives would conquer the world under the trade names Vermox, for treatment of humans, and Telmin and Mebenvet in veterinary medicine.
web page (section on parasitology)
Encyclopedia.com entry (Gale) et al., 2026-11-19: A biographical dictionary entry on Paul Janssen that places the discovery of mebendazole at Janssen Pharmaceutica in 1968 under compound code R 17635, marketed for humans as Vermox. The same entry records the 24 October 1961 share-swap takeover of the Janssen family company by Johnson & Johnson and the July 1981 mebendazole countertrade agreement with China. Reference-work biography, not a primary company record: use as corroboration of the 1968 Janssen discovery date and the R 17635 code, and as a pointer to J&J's 1961 acquisition (also recorded in this row's source under 'Through a share swap, the family company, with all departments, was taken over by J&J on 24 October 1961'). No study data. Page undated at article level; the Complete Dictionary of Scientific Biography volume carrying this entry is dated 2008, which is used as document_date. The entry does not describe Paul Janssen personally synthesising mebendazole; it attributes the discovery to 'researchers at Janssen Pharmaceutica'. Source edition: Complete Dictionary of Scientific Biography (2008). access date, page undated.
